Objective evaluation of changes in lens clarity after repeated injections of ranibizumab in patients with neovascular age-related macular degeneration-Reference-Cited by-同舟云学术

Objective evaluation of changes in lens clarity after repeated injections of ranibizumab in patients with neovascular age-related macular degeneration

Published:2022-04-21 Issue:9 Volume:260 Page:2897-2904
ISSN:0721-832X
Container-title:Graefe's Archive for Clinical and Experimental Ophthalmology
language:en
Short-container-title:Graefes Arch Clin Exp Ophthalmol

Author:

Altunel Orhan^ORCID,Irgat Saadet Gültekin,Özcura Fatih

Publisher

Springer Science and Business Media LLC

Subject

Cellular and Molecular Neuroscience,Sensory Systems,Ophthalmology

Link

https://link.springer.com/content/pdf/10.1007/s00417-022-05668-9.pdf

Reference32 articles.

1. Wong WL, Su X, Li X, Cheung CMG, Klein R, Cheng CY, Wong TY (2014) Global prevalence of age related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis. Lancet Global Health 2:106–116. https://doi.org/10.1016/S2214-109X(13)70145-1

2. Jager RD, Mieler WF, Miller JW (2008) Age-related macular degeneration. N Engl J Med 358:2606–2617. https://doi.org/10.1056/NEJMra0801537

3. Ferrara N (2009) VEGF-A: a critical regulator of blood vessel growth. Eur Cytokine Netw 20:158–163. https://doi.org/10.1684/ecn.2009.0170

4. Hernandez-Pastor LJ, Ortega A, Garcia-Layana A, Giraldez J (2008) Ranibizumab for neovascular age-related macular degeneration. Am J Health Syst Pharm 65:1805–1814. https://doi.org/10.2146/ajhp070342

5. Rosenfeld PJ, Brown DM, Heier JS, Boyer DS, Kaiser PK, Chung CY, Kim RY, MARINA Study Group (2006) Ranibizumab for neovascular age-related macular degeneration. N Engl J Med 355:1419–1431. https://doi.org/10.1056/NEJMoa054481